Patent classifications
A61K49/1887
Compositions for nanoconfinement induced contrast enhancement and methods of making and using thereof
Multivalent CT or MR contrast agents and methods of making and using thereof are described herein. The agents contain a moiety, such as a polymer, that provides multivalent attachment of CT or MR contrast agents. Examples include, but are not limited to, multivalent linear polymers, branched polymers, or hyperbranched polymers, such as dendrimers, and combinations thereof. The dendrimer is functionalized with one or more high Z-elements, such as iodine. The high Z-elements can be covalently or non-covalently bound to the dendrimer. The dendrimers are confined in order to enhance CT contrast. In some embodiments, the moiety is confined by encapsulating the dendrimers in a material to form particles, such as nanoparticles. In other embodiments, the dendrimer is confined by conjugating the moiety to a material, such as a polymer, which forms a gel upon contact with bodily fluids.
COMPOSITE EMBOLIZATION BEADS
The present invention relates to compositions and methods for imaging and treating various diseases and disorders, including cancers. The composition of the invention can include a plurality of biodegradable micro-beads, each embedding a plurality of nano-beads, further including a polymer, a radionuclide, a radionuclide chelator, a radioligand, a chemotherapeutic agent, and a cell-penetrating peptide. Upon injection into a blood vessel supplying a cancer tumor, the micro-beads lodge into the tumor and degrade, releasing the nano-beads with a therapeutic or diagnostic agent. The compositions and methods of the invention provide a more homogeneous and deeper distribution of radiation or chemotherapeutic agents throughout the target tumor. The micro-beads provide a local, sustained, and controlled delivery nano-beads including therapeutic or diagnostic agents.
MULTIFUNCTIONAL PH RESPONSIVE DRUG DELIVERY SYSTEM AND METHOD OF USE
A multi-functional drug composition capable of pH responsive drug release comprising siliceous nanoparticles having three dimensional cage structures type silica with thick pore walls and mesosilicalite, superparamagnetic iron oxide nanoparticles (SPION) and pharmaceutical composition thereof is disclosed. The drug delivery system is useful for targeting a drug to particular diseased tissues such as cancerous tissues.
MAGNETIC NANOPARTICLES FOR DESTROYING PATHOLOGICAL CELLS IN AN INDIVIDUAL
A composition including magnetic nanoparticles for use in the treatment of a tissue volume including pathological cells in an individual, wherein a portion only of the tissue volume is occupied by the magnetic nanoparticles upon administration of the composition to the individual and the magnetic nanoparticles are excited by radiation.
TUMOR-TARGETING, CLEARABLE HUMAN PROTEIN-BASED MRI NANOPROBES, AND COMPOSITIONS AND METHODS THEREOF
The invention provides a novel class of clearable, tumor-targeting and human protein-based MRI nanoprobes and contrast agents and their compositions, and methods of preparation and use thereof.
Magnetic nanoparticles for destroying pathological cells in an individual
Disclosed is a composition including magnetic nanoparticles for use in the treatment of a tissue volume including pathological cells in an individual, wherein a portion only of the tissue volume is occupied by the magnetic nanoparticles upon administration of the composition to the individual and the magnetic nanoparticles are excited by radiations.
COMPOSITE EMBOLIZATION BEADS
The present invention relates to compositions and methods for imaging and treating various diseases and disorders, including cancers. The composition of the invention can include a plurality of biodegradable micro-beads, each embedding a plurality of nano-beads, further including a polymer, a radionuclide, a radionuclide chelator, a radioligand, a chemotherapeutic agent, and a cell-penetrating peptide. Upon injection into a blood vessel supplying a cancer tumor, the micro-beads lodge into the tumor and degrade, releasing the nano-beads with a therapeutic or diagnostic agent. The compositions and methods of the invention provide a more homogeneous and deeper distribution of radiation or chemotherapeutic agents throughout the target tumor. The micro-beads provide a local, sustained, and controlled delivery nano-beads including therapeutic or diagnostic agents.
Antitumor composition based on hyaluronic acid and inorganic nanoparticles, method of preparation thereof and use thereof
The invention relates to an antitumor composition based on hydrophobized hyaluronan and inorganic nanoparticles stabilized by oleic acid. The hydrophobized hyaluronan in the form of an acylated hyaluronan serves in the composition as a carrier of inorganic nanoparticles. Out of the group of inorganic nanoparticles, the composition may comprise superparamagnetic nanoparticles, nanoparticles of ZnO and moreover, upconversion nanoparticles. Said composition is selectively cytotoxic with respect to both suspension and adherent tumor cell lines, especially with respect to tumor cell lines of colorectum carcinoma and adenocarcinoma, lung carcinoma, hepatocellular carcinoma and breast adenocarcinoma. The highest cytotoxic effects were observed in case of the composition based on an oleyl derivative of hyaluronan with SPIONs. The composition of acylated hyaluronan with SPIONs may also be advantageously used for an in vivo detection of accumulation of the composition in the body, preferably in a tumor or in liver. Said composition is sterilizable in the final package.
ULTRASMALL GADOLINIUM-INTERCALATED CARBON DOTS AS A RADIOSENSITIZING AGENT FOR CANCER
Gd-encapsulated carbonaceous dots (Gd@C-dots) hold great potential in clinical translation as T.sub.1 contrast agent for magnetic resonance imaging. Disclosed are methods of using said particles as radiosensitizing agents.
Use of Self-Assembled Nanocrystals
The present invention relates to a self-assembled structure for use in the treatment of mammalian cancer, the structure being between 50 and 1,500 nm in size and comprising a plurality of nanocrystals chosen from metal or metal oxide nanocrystals, a plurality of ligands being covalently linked to the surface of each of the nanocrystals, the ligands comprising hydrocarbon chains. The invention also relates to an injectable composition comprising said structure.